ENTROPY NEURODYNAMICS LIMITED — Share Issue/Capital Change 2021

Aug 31, 2021

==> picture [595 x 72] intentionally omitted <==

ASX ANNOUNCEMENT

Notice under Section 708A(5)(E) of the Corporations Act 2001 (Cth)

1 September 2021

Melbourne, Australia: Exopharm Limited (ASX: EX1) (“ Exopharm ” or the “ Company has issued 113,333 Ordinary Shares ( New Shares ) as per the Appendix 2A lodged earlier today.

The Company gives notice under section 708A(5)(e) of the Corporations Act 2001 (Cth) that:

1. The New Shares were issued without disclosure to investors under Part 6D.2 of the Corporations Act.

2. As at the date of this notice, the Company has complied with:

3. a. The provisions of Chapter 2M of the Corporations Act as they apply to the Company; and

4. b. Section 674 of the Corporations Act.

5. As at the date of this notice, there is no information that is “excluded information” of the type referred to in sections 708A(7) and 708A(8) of the Corporations Act that is required to be disclosed by the Company under section 708A(6)(e) of the Corporations Act.

For and on behalf of the Board.

Yours sincerely

Elizabeth McGregor Company Secretary

EXOPHARM LIMITED ACN: 163 765 991 ASX:EX1 Address: Level 17, 31 Queen Street Melbourne 3000 Telephone: 03 9111 0026 Email: info@exopharm.com Web: www.exopharm.com